Search Results - "Chen, Zinuo"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy by Zhao, Xiujuan, Lin, Xiaojing, Li, Ping, Chen, Zinuo, Zhang, Chengcheng, Manicassamy, Balaji, Rong, Lijun, Cui, Qinghua, Du, Ruikun

    Published in PLoS pathogens (04-08-2022)
    “…Reporter viruses provide powerful tools for both basic and applied virology studies, however, the creation and exploitation of reporter influenza A viruses…”
    Get full text
    Journal Article
  2. 2

    Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases by Chen, Zinuo, Cui, Qinghua, Cooper, Laura, Zhang, Pin, Lee, Hyun, Chen, Zhaoyu, Wang, Yanyan, Liu, Xiaoyun, Rong, Lijun, Du, Ruikun

    Published in Cell & bioscience (28-02-2021)
    “…In the urgent campaign to develop therapeutics against SARS-CoV-2, natural products have been an important source of new lead compounds. We herein identified…”
    Get full text
    Journal Article
  3. 3

    Punicalagin is a neuraminidase inhibitor of influenza viruses by Li, Ping, Du, Ruikun, Chen, Zinuo, Wang, Yanyan, Zhan, Peng, Liu, Xinyong, Kang, Dongwei, Chen, Zhaoyu, Zhao, Xiujuan, Wang, Lin, Rong, Lijun, Cui, Qinghua

    Published in Journal of medical virology (01-06-2021)
    “…Influenza A virus (IAV) causes great morbidity and mortality worldwide every year. However, there are only a limited number of drugs clinically available…”
    Get full text
    Journal Article
  4. 4

    SARS-CoV-2 cell entry and targeted antiviral development by Chen, Zinuo, Du, Ruikun, Galvan Achi, Jazmin M., Rong, Lijun, Cui, Qinghua

    Published in Acta pharmaceutica Sinica. B (01-12-2021)
    “…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the pandemic coronavirus disease 2019 (COVID-19), which threatens human…”
    Get full text
    Journal Article
  5. 5

    A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus by Zhao, Xiujuan, Wang, Yanyan, Cui, Qinghua, Li, Ping, Wang, Lin, Chen, Zinuo, Rong, Lijun, Du, Ruikun

    Published in Viruses (05-09-2019)
    “…Influenza A virus infections cause significant morbidity and mortality, and novel antivirals are urgently needed. Influenza RNA-dependent RNA polymerase (RdRp)…”
    Get full text
    Journal Article
  6. 6

    Material basis and pharmacodynamic mechanism of YangshenDingzhi granules in the intervention of viral pneumonia: Based on serum pharmacochemistry and network pharmacology by Xu, Huirong, Dong, Meiyue, Du, Ruikun, Zhang, Chengcheng, Chen, Zinuo, Tian, Guangyu, Cui, Qinghua, Li, Kejian

    Published in Animal models and experimental medicine (01-06-2024)
    “…Background YangshenDingzhi granules (YSDZ) are clinically effective in preventing and treating COVID‐19. The present study elucidates the underlying mechanism…”
    Get full text
    Journal Article
  7. 7

    Combining virus-based affinity ultrafiltration method with serum pharmacochemistry to identify the antiviral pharmacodynamic substances in licorice by Li, Zhongyuan, Dong, Meiyue, Chen, Zinuo, Zhang, Chengcheng, Jiang, Jiayu, Liu, Miaomiao, Cui, Qinghua

    Published in Journal of ethnopharmacology (10-02-2025)
    “…Liorice (Glycyrrhiza uralensis Fisch.), a widely used Chinese herbal medicine, is frequently employed in clinical practice to treat viral pneumonia. However,…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro by Du, Ruikun, Cooper, Laura, Chen, Zinuo, Lee, Hyun, Rong, Lijun, Cui, Qinghua

    Published in Antiviral research (01-06-2021)
    “…The emerging SARS-CoV-2 infection is the cause of the global COVID-19 pandemic. To date, there are limited therapeutic options available to fight this disease…”
    Get full text
    Journal Article
  10. 10

    Licochalcone A plays dual antiviral roles by inhibiting RSV and protecting against host damage by Li, Zhongyuan, Li, Baohong, Chen, Zinuo, Xu, Jinke, El Sabbagh, Asma, Zhao, Yangang, Du, Ruikun, Rong, Lijun, Tian, Jingzhen, Cui, Qinghua

    Published in Journal of medical virology (01-08-2023)
    “…Respiratory syncytial virus (RSV) causes lower respiratory tract diseases and bronchiolitis in children and elderly individuals. There are no effective drugs…”
    Get full text
    Journal Article
  11. 11

    Revisiting influenza A virus life cycle from a perspective of genome balance by Du, Ruikun, Cui, Qinghua, Chen, Zinuo, Zhao, Xiujuan, Lin, Xiaojing, Rong, Lijun

    Published in Virologica Sinica (01-02-2023)
    “…Influenza A virus (IAV) genome comprises eight negative-sense RNA segments, of which the replication is well orchestrated and the delicate balance of multiple…”
    Get full text
    Journal Article
  12. 12

    Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2 by Chen, Zinuo, Du, Ruikun, Cooper, Laura, Achi, Jazmin G., Dong, Meiyue, Ran, Yan, Zhang, Jiwei, Zhan, Peng, Rong, Lijun, Cui, Qinghua

    Published in Journal of medical virology (01-03-2023)
    “…The ongoing pandemic of coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has posed a major public…”
    Get full text
    Journal Article
  13. 13

    Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor by Dong, Meiyue, Wang, Yanyan, Li, Ping, Chen, Zinuo, Anirudhan, Varada, Cui, Qinghua, Rong, Lijun, Du, Ruikun

    Published in Virologica Sinica (01-12-2023)
    “…Influenza A virus (IAV) poses a global public health concern and remains an imminent threat to human health. Emerging antiviral resistance to the currently…”
    Get full text
    Journal Article
  14. 14

    Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL pro by Du, Ruikun, Cooper, Laura, Chen, Zinuo, Lee, Hyun, Rong, Lijun, Cui, Qinghua

    Published in Antiviral research (01-06-2021)
    “…The emerging SARS-CoV-2 infection is the cause of the global COVID-19 pandemic. To date, there are limited therapeutic options available to fight this disease…”
    Get full text
    Journal Article